Rivalry - CEO, Steven Salz.
CEO, Steven Salz.
Source: LinkedIn.
  • Rivalry (RVLY) co-founder and CEO, Steven Salz will speak at the Canaccord Genuity 2021 Digital Gaming Summit at 9:30 am EST on Tuesday November 30th
  • The conference will offer investors an opportunity to engage with global industry leaders across the OSB, iGaming and esports landscape
  • Rivalry owns and operates a sports betting and media property offering fully regulated online wagering on esports, traditional sports and casino games
  • Rivalry Corp. (RVLY) is down 5.02 per cent on the day, trading at C$2.27 per share at 4 pm EST

Rivalry (RVLY) co-founder and CEO, Steven Salz will participate at the Canaccord Genuity 2021 Digital Gaming Summit.

Steven will engage in a “fireside chat” at 9:30 am EST on Tuesday, November 30th.

The conference will offer investors an opportunity to engage with global industry leaders across the OSB, iGaming and esports landscape.

A replay of the webcast will be available for 90 days on the “Events & Presentations” section of the company’s website.

Rivalry Corp. wholly owns and operates Rivalry Limited, a leading sports betting and media property offering fully regulated online wagering on esports, traditional sports, and casinos for the next generation of bettors.

Based in Toronto, Rivalry operates a global team in more than 18 countries and growing.

Rivalry Limited was granted its Isle of Man license in early 2018, officially launching in August of that year, and the company is currently in the process of obtaining additional country licenses. Rivalry has a variety of originally developed products, including Quest and a casino game called Rushlane.

Rivalry Corp. (RVLY) is down 5.02 per cent on the day, trading at C$2.27 per share at 4 pm EST.

More From The Market Online

Liberty Defense expands its international customer base

Liberty Defense Holdings (TSXV:SCAN), a provider of artificial intelligence technologies, expands its international customer base.

Unsung profits: Three microcap stocks with a strong case for value

A key factor behind picking winning microcap value stocks is identifying dislocations between company performance and market perception.

Theralase advances cancer research after private placement

Theralase Technologies (TSXV:TLT) closes a non-brokered private placement offering of 4.1 million shares for gross proceeds of C$750,200.